AvantorMEX:AVTR 61 Days Payable is 62.32 as of Mar. 2026, which is 16% above its 10-year median of 53.59. GuruFocus rates MEX:AVTR with a GF Score™ of 61/100 and a GF Value™ of MXN437.68. The stock has 4 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Avantor ranks worse than 60.25% on this metric.
Avantor's average Accounts Payable for the
three
months ended in Mar. 2026 was MXN13,309 Mil. Avantor's Cost of Goods Sold for the
three
months ended in Mar. 2026 was MXN19,488 Mil.
Hence, Avantor's Days Payable for the
three
months ended in Mar. 2026 was 62.32.
The historical rank and industry rank for Avantor's Days Payable or its related term are showing as below:
MEX:AVTR'
s Days Payable Range Over the Past 10 Years
Min: 49.51 Med: 53.59 Max: 242.86
Current: 58.4
During the past 10 years, Avantor's highest Days Payable was 242.86. The lowest was 49.51. And the median was 53.59.
MEX:AVTR's Days Payable is ranked worse than 60.25% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.07
vs MEX:AVTR: 58.40
Avantor's Days Payable
increased
from Mar. 2025 (59.11) to Mar. 2026 (62.32).
It may suggest that Avantordelayed paying its suppliers.
Avantor Days Payable Related Terms
Avantor Days Payable Historical Data
* Premium members only.
The historical data trend for Avantor's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:AVTR vs ATR, TFX, RGEN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Avantor's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avantor Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Avantor's Days Payable distribution charts can be found below:
* The bar in red indicates where Avantor's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Avantor's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avantor (MEX:AVTR) has a Days Payable of 62.32 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Avantor and its competitors. This is 16% above median its historical median of 53.59. Over the past decade, Avantor's Days Payable has ranged from 49.51 to 242.86. According to the industry distribution chart, Avantor ranks #479 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 60.3%.
Is Avantor's Days Payable too high?
Avantor's current Days Payable of 62.32 is 16% above median its 10-year median of 53.59. Over the past 10 years, this metric has ranged from a low of 49.51 to a high of 242.86. The Medical Devices & Instruments industry median Days Payable is 68.07. Avantor's value of 62.32 is 8.4% below this industry median. Based on the distribution chart, Avantor ranks #479 out of 795 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Avantor has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does Avantor's Days Payable compare to ATR and TFX?
According to the Medical Devices & Instruments industry distribution chart, Avantor ranks #479 out of 795 companies for Days Payable. This places Avantor in the lower half of its industry. The industry median Days Payable is 68.07. Avantor's value of 62.32 is 8.4% below this benchmark. Historically, Avantor's own Days Payable has ranged from 49.51 to 242.86 over the past decade. While the company's 10-year median is 53.59 vs. the industry median of 68.07, Avantor has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.07, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avantor's current Days Payable of 62.32 is 8.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Avantor and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avantor's current Days Payable is 62.32, which is 16% above median its own 10-year median of 53.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avantor stock overvalued right now?
Avantor (MEX:AVTR) has a current Days Payable of 62.32. The stock's GF Value™ is MXN437.68, compared to a current price of MXN244.00 — trading 44.3% below its estimated fair value. The current Days Payable is 62.32, which is 16% above median its 10-year median of 53.59 and 8.4% below the Medical Devices & Instruments industry median of 68.07. Avantor's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Avantor (MEX:AVTR), the current Days Payable is 62.32 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Avantor (MEX:AVTR) Overvalued in 2026?
Based on GuruFocus' analysis, Avantor stock appears to be undervalued.
The current stock price of MXN244.00 is trading 44.3% below its estimated GF Value™ of MXN437.68.
Key valuation signals for MEX:AVTR:
Days Payable: 62.32 (16% above median its 10-year median of 53.59)
GF Value™: MXN437.68 vs. price of MXN244.00 (44.3% below fair value)
Industry Position: 8.4% below the Medical Devices & Instruments median (#479 of 795)
No single metric tells the full story. See the MEX:AVTR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
61GF Score
Get the complete analysis for MEX:AVTR
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:AVTR has been successfully added to your 
